JP2021533150A5 - - Google Patents
Info
- Publication number
- JP2021533150A5 JP2021533150A5 JP2021506287A JP2021506287A JP2021533150A5 JP 2021533150 A5 JP2021533150 A5 JP 2021533150A5 JP 2021506287 A JP2021506287 A JP 2021506287A JP 2021506287 A JP2021506287 A JP 2021506287A JP 2021533150 A5 JP2021533150 A5 JP 2021533150A5
- Authority
- JP
- Japan
- Prior art keywords
- antibiotic
- composition according
- polymyxin
- adsorbent
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18187409.0 | 2018-08-05 | ||
| EP18187409 | 2018-08-05 | ||
| PCT/EP2019/071026 WO2020030593A1 (en) | 2018-08-05 | 2019-08-05 | Compositions for the treatment of graft versus host disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021533150A JP2021533150A (ja) | 2021-12-02 |
| JP2021533150A5 true JP2021533150A5 (enExample) | 2022-06-27 |
Family
ID=63165229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506287A Pending JP2021533150A (ja) | 2018-08-05 | 2019-08-05 | 移植片対宿主病の治療のための組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210290741A1 (enExample) |
| EP (1) | EP3829552A1 (enExample) |
| JP (1) | JP2021533150A (enExample) |
| KR (1) | KR20210040395A (enExample) |
| CN (1) | CN112689506A (enExample) |
| AU (1) | AU2019320483A1 (enExample) |
| BR (1) | BR112021002105A2 (enExample) |
| CA (1) | CA3106433A1 (enExample) |
| IL (1) | IL280589A (enExample) |
| MX (1) | MX2021001393A (enExample) |
| WO (1) | WO2020030593A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3136833A1 (en) * | 2019-05-06 | 2020-11-12 | Synthetic Biologics, Inc. | Beta-lactamase compositions for treatment of graft versus host disease |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2429095T3 (es) | 2005-05-18 | 2013-11-13 | Da Volterra | Aporte colónico de adsorbentes |
| US8048413B2 (en) | 2006-05-17 | 2011-11-01 | Helene Huguet | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| FI119190B (fi) | 2006-06-21 | 2008-08-29 | Ipsat Therapies Oy | Modifioitu beta-laktamaasi ja menetelmä sen valmistamiseksi |
| KR101820374B1 (ko) | 2010-02-23 | 2018-01-19 | 다 볼떼라 | 장 내 흡착제의 경구 전달을 위한 제형 |
| FI20105572A0 (fi) | 2010-05-24 | 2010-05-24 | Prevab R Lcc | Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt |
| JP6456830B2 (ja) | 2012-09-21 | 2019-01-23 | フェリング ベスローテン フェンノートシャップ | 医薬組成物 |
| BR112016023360B1 (pt) | 2014-04-17 | 2023-03-07 | Synthetic Biologics, Inc | Beta-lactamase e seu uso |
| WO2016057744A1 (en) * | 2014-10-08 | 2016-04-14 | Synthetic Biologics, Inc. | Beta-lactamase formulations and uses thereof |
| FR3027307B1 (fr) | 2014-10-16 | 2016-11-04 | Azurrx Sas | Molecule proteique hybride apte a inhiber au moins un antibiotique et composition pharmaceutique la comportant |
| MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| WO2016086161A1 (en) * | 2014-11-25 | 2016-06-02 | Memorial Sloan-Kettering Cancer Center | Intestinal microbiota and gvhd |
-
2019
- 2019-08-05 US US17/263,828 patent/US20210290741A1/en not_active Abandoned
- 2019-08-05 JP JP2021506287A patent/JP2021533150A/ja active Pending
- 2019-08-05 EP EP19746500.8A patent/EP3829552A1/en not_active Withdrawn
- 2019-08-05 BR BR112021002105-1A patent/BR112021002105A2/pt not_active Application Discontinuation
- 2019-08-05 KR KR1020217005467A patent/KR20210040395A/ko not_active Ceased
- 2019-08-05 AU AU2019320483A patent/AU2019320483A1/en not_active Abandoned
- 2019-08-05 CA CA3106433A patent/CA3106433A1/en active Pending
- 2019-08-05 MX MX2021001393A patent/MX2021001393A/es unknown
- 2019-08-05 CN CN201980050483.7A patent/CN112689506A/zh active Pending
- 2019-08-05 WO PCT/EP2019/071026 patent/WO2020030593A1/en not_active Ceased
-
2021
- 2021-02-02 IL IL280589A patent/IL280589A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5371755B2 (ja) | β−ラクタム系抗生物質と緩衝成分を含有する抗生物質複方 | |
| JP2003321389A5 (enExample) | ||
| CN102319246B (zh) | 包含抗菌药以及一种选自麝香草酚、香芹酚的活性物质的药物组合物 | |
| CN110520114B (zh) | 包含银和抗生素的纳米体系及其用于治疗细菌感染的用途 | |
| JP2004339238A5 (enExample) | ||
| FI3006038T3 (fi) | Oritavansiinin yksittäisannokset bakteeri-infektion hoitoon tai ehkäisyyn | |
| CN113939306A (zh) | 用于治疗涉及生物膜的细菌感染的阿法比星 | |
| AU2017203136A1 (en) | Methods for treating bacterial infection | |
| JP2021533150A5 (enExample) | ||
| Butler et al. | Natural product inspired antibiotics approved for human use–1943 to 2025 | |
| JP7309214B2 (ja) | 抗菌性物質として有益なジフェニル置換チオフェン－２－アミド誘導体およびそれらの医薬組成物 | |
| RU2021105528A (ru) | Композиции для лечения реакции трансплантат против хозяина | |
| EP2778166A1 (en) | Thioxanthene derivatives for the treatment of infectious diseases | |
| KR20210040395A (ko) | 이식편 대 숙주 질환의 치료를 위한 조성물 | |
| KR20210040997A (ko) | 항암제 효능의 개선 방법 | |
| JP2010505744A (ja) | 細菌感染治療の改善された方法 | |
| EP1368010A2 (en) | Antibacterial compositions which contain oxapenem-3-carboxylic acids and antibiotics | |
| GB2490671A (en) | Pharmaceutical preparation and use | |
| Labu et al. | Application of antimicrobial agents and its unwanted effects |